
( (S 
    (NP-SBJ (NNP Food) 
      (CC and)
      (NNP Drug) (NNP Administration) (NN spokesman) (NNP Jeff) (NNP Nesbit) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ (DT the) (NN agency) )
          (VP (VBZ has) 
            (VP (VBN turned) 
              (PRT (RP over) )
              (NP (NN evidence) )
              (PP-LOC (IN in) 
                (NP 
                  (NP (DT a) (JJ criminal) (NN investigation) )
                  (VP (VBG concerning) 
                    (NP (NNP Vitarine) (NNP Pharmaceuticals) (NNP Inc.) ))))
              (PP-CLR (TO to) 
                (NP 
                  (NP 
                    (NP (DT the) (NNP U.S.) (NNP Attorney) (POS 's) )
                    (NN office) )
                  (PP-LOC (IN in) 
                    (NP (NNP Baltimore) )))))))))
    (. .) ))
( (S 
    (NP-SBJ-1 (DT Neither) 
      (NP (NNP Vitarine) )
      (CC nor) 
      (NP 
        (NP (DT any) )
        (PP (IN of) 
          (NP 
            (NP (DT the) 
              (NAC-LOC (NNP Springfield) (NNP Gardens) 
                (, ,)
                (NNP N.Y.) 
                (, ,)
                )
              (NN company) (POS 's) )
            (NNS officials) (CC or) (NNS employees) ))))
    (VP (VBP have) 
      (VP (VBN been) 
        (VP (VBN charged) 
          (NP (-NONE- *-1) )
          (PP-CLR (IN with) 
            (NP (DT any) (NNS crimes) )))))
    (. .) ))
( (S 
    (NP-SBJ (NNP Vitarine) )
    (VP 
      (VP (VBD won) 
        (NP (NN approval) 
          (S 
            (NP-SBJ (-NONE- *) )
            (VP (TO to) 
              (VP (VB market) 
                (NP 
                  (NP (DT a) (NN version) )
                  (PP (IN of) 
                    (NP (DT a) (NN blood) (NN pressure) (NN medicine) ))))))))
      (CC but) 
      (VP (VBD acknowledged) 
        (SBAR (IN that) 
          (S 
            (NP-SBJ (PRP it) )
            (VP (VBD substituted) 
              (NP 
                (NP (DT a) (NNP SmithKline) (NNP Beecham) (NNP PLC) (NN product) ))
              (PP-CLR (IN as) 
                (NP (PRP$ its) (JJ own) ))
              (PP-LOC (IN in) 
                (NP (NNS tests) )))))))
    (. .) ))
( (S 
    (NP-SBJ (NNP Mr.) (NNP Nesbit) )
    (ADVP (RB also) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ (DT the) (NNP FDA) )
          (VP (VBZ has) 
            (VP (VBN asked) 
              (NP-1 (NNP Bolar) (NNP Pharmaceutical) (NNP Co.) )
              (S 
                (NP-SBJ (-NONE- *-1) )
                (VP (TO to) 
                  (VP (VB recall) 
                    (PP-LOC (IN at) 
                      (NP (DT the) (JJ retail) (NN level) ))
                    (NP (PRP$ its) (JJ urinary) (NN tract) (NN antibiotic) )))))))))
    (. .) ))
( (S 
    (S-TPC-1 (CC But) 
      (ADVP-TMP (RB so) (RB far) )
      (NP-SBJ (DT the) (NN company) )
      (VP (VBZ has) (RB n't) 
        (VP (VBN complied) 
          (PP-CLR (IN with) 
            (NP (DT that) (NN request) )))))
    (, ,) 
    (NP-SBJ (DT the) (NN spokesman) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S (-NONE- *T*-1) )))
    (. .) ))
( (S 
    (S-TPC-2 
      (NP-SBJ-1 
        (NP (NNP Bolar) )
        (, ,) 
        (NP 
          (NP (DT the) (NN subject) )
          (PP (IN of) 
            (NP 
              (NP (DT a) (JJ criminal) (NN investigation) )
              (PP (IN by) 
                (NP 
                  (NP (DT the) (NNP FDA) )
                  (CC and) 
                  (NP 
                    (NP 
                      (NP (DT the) (NNP Inspector) (NNP General) (POS 's) )
                      (NN office) )
                    (PP (IN of) 
                      (NP (DT the) (NNP Health) 
                        (CC and)
                        (NNP Human) (NNP Services) (NNP Department) ))))))))
        (, ,) )
      (VP 
        (ADVP (RB only) )
        (VBD agreed) 
        (S 
          (NP-SBJ (-NONE- *-1) )
          (VP (TO to) 
            (VP (VB recall) 
              (NP 
                (NP (CD two) (NNS strengths) )
                (PP (IN of) 
                  (NP 
                    (NP (PRP$ its) (NN version) )
                    (PP (IN of) 
                      (NP (NNP Macrodantin) )))))
              (`` ``) 
              (ADVP 
                (ADVP (RB as) (RB far) (RB down) )
                (PP (IN as) 
                  (NP 
                    (NP (JJ direct) (NNS customers) )
                    (, ,) (RB mostly) 
                    (NP (NNS wholesalers) )))))))))
    (, ,) ('' '') 
    (NP-SBJ (NNP Mr.) (NNP Nesbit) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S (-NONE- *T*-2) )))
    (. .) ))
( (S 
    (NP-SBJ 
      (NP (NNP Bolar) )
      (, ,) 
      (PP (IN of) 
        (NP 
          (NP (NNP Copiague) )
          (, ,) 
          (NP (NNP N.Y.) )
          (, ,) )))
    (ADVP-TMP (RBR earlier) )
    (VP (VBD began) 
      (NP 
        (NP (DT a) (JJ voluntary) (NN recall) )
        (PP (IN of) 
          (NP 
            (NP (DT both) (PRP$ its) 
              (ADJP 
                (ADJP (CD 100) (NN milligram) )
                (CC and) 
                (ADJP (CD 50) (NN milligram) ))
              (NNS versions) )
            (PP (IN of) 
              (NP (DT the) (NN drug) ))))))
    (. .) ))
( (S 
    (NP-SBJ (DT The) (NNP FDA) )
    (VP (VBZ has) 
      (VP (VBD said) 
        (SBAR (-NONE- 0) 
          (S 
            (NP-SBJ (PRP it) )
            (VP (VBD presented) 
              (NP 
                (NP (NN evidence) )
                (SBAR 
                  (WHNP-1 (-NONE- 0) )
                  (S 
                    (NP-SBJ (PRP it) )
                    (VP (VBD uncovered) 
                      (NP (-NONE- *T*-1) ))))
                (VP (-NONE- *ICH*-2) ))
              (PP (TO to) 
                (NP (DT the) (NN company) ))
              (VP-2 (VBG indicating) 
                (SBAR (IN that) 
                  (S 
                    (NP-SBJ-3 (NNP Bolar) )
                    (VP (VBD substituted) 
                      (NP (DT the) (JJ brand-name) (NN product) )
                      (PP-CLR (IN for) 
                        (NP (PRP$ its) (JJ own) ))
                      (S-PRP 
                        (NP-SBJ (-NONE- *-3) )
                        (VP (TO to) 
                          (VP (VB gain) 
                            (NP (NN government) (NN approval) 
                              (S 
                                (NP-SBJ (-NONE- *) )
                                (VP (TO to) 
                                  (VP (VB sell) 
                                    (NP 
                                      (NP (JJ generic) (NNS versions) )
                                      (PP (IN of) 
                                        (NP (NNP Macrodantin) )))))))))))))))))))
    (. .) ))
( (S 
    (NP-SBJ (NNP Bolar) )
    (VP (VBZ has) 
      (VP (VBN denied) 
        (SBAR (IN that) 
          (S 
            (NP-SBJ (PRP it) )
            (VP (VBD switched) 
              (NP (DT the) (JJ brand-name) (NN product) )
              (PP-CLR (IN for) 
                (NP (PRP$ its) (JJ own) ))
              (PP-LOC (IN in) 
                (NP (JJ such) (NN testing) )))))))
    (. .) ))
